N6-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2 DOI
Yuan Li, Linjian Xia,

Kaifen Tan

и другие.

Nature Genetics, Год журнала: 2020, Номер 52(9), С. 870 - 877

Опубликована: Авг. 10, 2020

Язык: Английский

Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers DOI Creative Commons
Hailing Shi, Jiangbo Wei, Chuan He

и другие.

Molecular Cell, Год журнала: 2019, Номер 74(4), С. 640 - 650

Опубликована: Май 1, 2019

Язык: Английский

Процитировано

1478

Functions of N6-methyladenosine and its role in cancer DOI Creative Commons

Liuer He,

Huiyu Li,

Anqi Wu

и другие.

Molecular Cancer, Год журнала: 2019, Номер 18(1)

Опубликована: Дек. 1, 2019

N6-methyladenosine (m6A) is methylation that occurs in the N6-position of adenosine, which most prevalent internal modification on eukaryotic mRNA. Accumulating evidence suggests m6A modulates gene expression, thereby regulating cellular processes ranging from cell self-renewal, differentiation, invasion and apoptosis. M6A installed by methyltransferases, removed demethylases recognized reader proteins, regulate RNA metabolism including translation, splicing, export, degradation microRNA processing. Alteration levels participates cancer pathogenesis development via expression tumor-related genes like BRD4, MYC, SOCS2 EGFR. In this review, we elaborate recent advances research enzymes. We also highlight underlying mechanism progression. Finally, review corresponding potential targets therapy.

Язык: Английский

Процитировано

1096

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer DOI Creative Commons
Huilin Huang, Hengyou Weng, Jianjun Chen

и другие.

Cancer Cell, Год журнала: 2020, Номер 37(3), С. 270 - 288

Опубликована: Март 1, 2020

Язык: Английский

Процитировано

940

Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion DOI Creative Commons
Rui Su, Lei Dong, Yangchan Li

и другие.

Cancer Cell, Год журнала: 2020, Номер 38(1), С. 79 - 96.e11

Опубликована: Июнь 11, 2020

Язык: Английский

Процитировано

584

N 6 -methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription DOI Open Access
Jun Liu, Xiaoyang Dou, Chuanyuan Chen

и другие.

Science, Год журнала: 2020, Номер 367(6477), С. 580 - 586

Опубликована: Янв. 17, 2020

A new layer of transcriptional control N 6 -methyladenosine (m A) is the most abundant messenger RNA modification in almost all eukaryotes. Liu et al. now show that m also cotranscriptionally added onto various chromosome-associated regulatory RNAs (carRNAs) mammalian cells. Disruption these increases their abundance and promotes gene transcription by increasing chromatin accessibility. Thus, serves as a switch to regulate carRNA levels tuning nearby state downstream transcription. Science , this issue p. 580

Язык: Английский

Процитировано

539

Transcriptome-wide Mapping of Internal N7-Methylguanosine Methylome in Mammalian mRNA DOI Creative Commons
Lisheng Zhang, Chang Liu, Honghui Ma

и другие.

Molecular Cell, Год журнала: 2019, Номер 74(6), С. 1304 - 1316.e8

Опубликована: Апрель 25, 2019

Язык: Английский

Процитировано

411

Small RNAs are modified with N-glycans and displayed on the surface of living cells DOI Creative Commons
Ryan A. Flynn, Kayvon Pedram, Stacy A. Malaker

и другие.

Cell, Год журнала: 2021, Номер 184(12), С. 3109 - 3124.e22

Опубликована: Май 17, 2021

Язык: Английский

Процитировано

407

The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities DOI Creative Commons

Paz Nombela,

Borja Miguel‐López, Sandra Blanco

и другие.

Molecular Cancer, Год журнала: 2021, Номер 20(1)

Опубликована: Янв. 18, 2021

Abstract RNA modifications have recently emerged as critical posttranscriptional regulators of gene expression programmes. Significant advances been made in understanding the functional role regulating coding and non-coding processing function, which turn thoroughly shape distinct They affect diverse biological processes, correct deposition many these is required for normal development. Alterations their are implicated several diseases, including cancer. In this Review, we focus on occurrence N 6 -methyladenosine (m A), 5-methylcytosine 5 C) pseudouridine (Ψ) RNAs describe physiopathological We will highlight latest insights into mechanisms how influence tumour development, maintenance, progression. Finally, summarize development small molecule inhibitors that target specific writers or erasers to rewind epitranscriptome a cancer cell therapeutic potential.

Язык: Английский

Процитировано

358

N6-Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation DOI
Honghui Ma, Xiaoyun Wang, Jia‐Bin Cai

и другие.

Nature Chemical Biology, Год журнала: 2018, Номер 15(1), С. 88 - 94

Опубликована: Дек. 4, 2018

Язык: Английский

Процитировано

343

Cap-specific terminal N 6 -methylation of RNA by an RNA polymerase II–associated methyltransferase DOI Open Access
Shinichiro Akichika, Seiichi Hirano, Yuichi Shichino

и другие.

Science, Год журнала: 2018, Номер 363(6423)

Опубликована: Ноя. 23, 2018

A cap-specific m 6 writer N ,2′- O -dimethyladenosine (m Am) is present at the transcription start nucleotide of capped mRNAs in vertebrates. Akichika et al. quantified abundance this modification transcriptome and identified protein, adenosine methyltransferase (CAPAM), needed for modification. CAPAM contains a unique structure that recognizes -methyladenosine A) as substrate. The protein interacts with RNA polymerase II, suggesting occurs cotranscriptionally. Am promotes translation eIF4E-independent fashion. Science , issue p. eaav0080

Язык: Английский

Процитировано

322